Breast cancer
Breast cancer, one of the most common cancers among women globally, arises from breast tissue, typically from the inner lining of mammary ducts or the lobules supplying them. Breast cancer can present as a lump in the breast, changes in breast shape, dimpling of the skin, or abnormal nipple discharge. While the exact causes remain complex and multifactorial, risk factors include genetics, age, lifestyle, and hormonal influences. Early detection, primarily through mammography screening, significantly improves prognosis and survival rates. Treatment options tailored to each individual may include surgery, chemotherapy, radiation therapy, and hormone or targeted therapies. Recent advancements in research are focusing on understanding the molecular subtypes of breast cancer, leading to more personalized and effective treatment strategies. Breast cancer awareness and education campaigns emphasize the importance of regular screenings and self-examinations in early detection and successful treatment outcomes.
Breast cancer
Latest Posts
-
AI-Powered Blood Test Enables Early Breast Cancer Detection
Key Points An AI-powered blood test detects and classifies breast cancer at stage 1a. Integrates Raman spectroscopy and machine learning for non-invasive diagnosis. Promises enhanced early detection and personalized cancer treatment. Introduction Researchers at the University of…
-
Flaxseed’s Role in Breast Health: Gut Microbiome and miRNA Connections
This study, published in the Microbiology Spectrum journal, explores the connection between the human gut microbiome and breast health. Researchers focused on the influence of flaxseed components called lignans on this relationship. Flaxseed (FS) is known to…
-
Advancements in Breast Cancer Detection: AI-Based Risk Model Proves Effective in European Study
An international study led by Karolinska Institutet in Sweden, published in The Lancet Regional Health – Europe, demonstrates the effectiveness of an AI-based risk model in identifying women at high risk of breast cancer during mammography screenings.…
-
Revolutionizing Breast Cancer Prognosis with Novel Digital Biomarker Histomic Prognostic Signature(HiPS): A New AI-Driven Approach
The Northwestern Medicine study introduces a novel digital biomarker, the Histomic Prognostic Signature (HiPS), using a new deep learning-based AI tool designed to improve breast cancer prognosis. Traditional methods, like the Nottingham criteria used by pathologists, focus…
-
Improvements in optical mammography to advance breast cancer diagnostics
Researchers from Politecnico di Milano, Italy report improvements in the design of optical mammography used in diagnosis and monitoring of breast cancer. They report increase sensitivity by a thousandfold.This research is presented at Biomedical Optics meeting 2018.…
-
Using ribosomal protein expression patterns as cancer biomarker
A research team at the University of Basel’s Biozentrum has investigated the expression of ribosomal proteins in a wide range of human tissues including tumors and discovered a cancer type specific signature. The study is reported in journal Genome Biology.…
-
Piperlongumine, chemical from Indian pepper plant inhibits enzyme in cancer cells
UT Southwestern Medical Center scientists have uncovered the chemical process behind anti-cancer properties of a spicy Indian pepper plant called the long pepper, whose suspected medicinal properties date back thousands of years. The study is published in…
-
Calcium channel blockers used for hypertension has potential to block cancer invasion
By screening already approved drugs, the team led by Postdoctoral Researcher Guillaume Jacquemet and Academy Professor Johanna Ivaska has discovered that calcium channel blockers can efficiently stop cancer cell invasion in vitro. Calcium channel blockers are currently…
-
Trastuzumab biosimilar (MYL-14010) shown effective in breast cancer clinical trial
Among women with metastatic breast cancer, treatment with a drug that is biosimilar to the breast cancer drug trastuzumab resulted in an equivalent overall response rate at 24 weeks compared with trastuzumab, according to a study published…
You must be logged in to post a comment.